Evolving a Market Access Strategy to Improve Patient Access

How pharmaceutical companies should address payer needs during drug development and the role of market access through clinical development.

Read the Full PharmExec Byline

Sanofi’s David Bower and Guidehouse’s Agata Wiśniowska share insights on how addressing payer needs in the product development process can help companies increase patient access to their novel treatments. They also explore the differences between payer and regulator considerations in clinical development, the role market access plays, and why market access involvement in drug development may become more important over time.

Read more in PharmExec.

Back to top